Editorial comments for neoadjuvant chemo-radiotherapy in the treatment of locally advanced squamous cell esophageal cancer

Vadim G Pischik^{1

2}

Affiliations

¹ Department of Thoracic Surgery, Federal Hospital #122, Saint Petersburg, Russia.
² Faculty of Medicine, Saint Petersburg State University, Saint Petersburg, Russia.

Editorial

Vadim G Pischik. J Thorac Dis. 2018 Nov.

. 2018 Nov;10(11):5979-5981.

doi: 10.21037/jtd.2018.10.81.

Vadim G Pischik^{1

2}

¹ Department of Thoracic Surgery, Federal Hospital #122, Saint Petersburg, Russia.
² Faculty of Medicine, Saint Petersburg State University, Saint Petersburg, Russia.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Lordick F, D'Journo XB, Cerfolio RJ, Korst RJ, Novoa NM, Swanson SJ, Brunelli A, Ismail M, Fernando HC, Zhang X, Li Q, Wang G, Chen B, Mao T, Kong M, Guo X, Lin T, Liu M, Fu J; AME Thoracic Surgery Collaborative Group. Yang H, et al. J Clin Oncol. 2018 Sep 20;36(27):2796-2803. doi: 10.1200/JCO.2018.79.1483. Epub 2018 Aug 8. J Clin Oncol. 2018. PMID: 30089078 Free PMC article. Clinical Trial.

1. Yang H, Liu H, Chen Y, et al. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. J Clin Oncol 2018;36:2796-803. 10.1200/JCO.2018.79.1483 - DOI - PMC - PubMed
1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. 10.3322/caac.21262 - DOI - PubMed
1. Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27:v50-7. 10.1093/annonc/mdw329 - DOI - PubMed
1. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 2013;381:400-12. 10.1016/S0140-6736(12)60643-6 - DOI - PubMed
1. Deng J, Wang C, Xiang M, et al. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma. Diagn Pathol 2014;9:151. 10.1186/1746-1596-9-151 - DOI - PMC - PubMed